Marinus Pharmaceuticals completes $70 million stock sale

The company is on track to file its first new drug application in 2021.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.